Latest Clinical Trials
A prospective randomized, double-blinded, placebo-controlled pilot study of lactobacillus GG in the treatment of atopic dermatitis
Anacor Pharmaceuticals announces positive results from phase 2a clinical trial of AN2728 in psoriasis patients
A phase II randomized bilateral comparison study of bexarotene 1% gel in alopecia areata
Methotrexate-treated psoriasis patients transitioning to adalimumab: Efficacy and safety outcomes
Arana announces start of phase II trial for lead compound
CombinatoRx drug candidate CRx-191 demonstrates positive phase 2 results in psoriasis
Psoriasis patients with or without psoriatic arthritis experience improvements in skin and in patient-reported outcomes upon treatment with adalimumab: Results from the first 16 weeks of REVEAL
Certolizumab pegol improved health-related quality of life in patients with psoriasis: Data from a phase II study
Safety and efficacy of an extended course of alefacept of up to 12 additional weekly doses following a standard 12-week course of alefacept
Low incidence of tuberculosis in patients receiving etanercept therapy: Results from a combined analysis of US and ex-US double-blind trials and their open label extensions